Christopher Boerner
Net worth: 9 M $ as of 2026-02-27
Net worth: 9 M $ as of 2026-02-27
Dr. Christopher S.
Boerner is a Chairman & Chief Executive Officer at Bristol Myers Squibb Co. He is on the Board of Directors at Capital Health System, Inc. and Pharmaceutical Research & Manufacturers of America.
Dr. Boerner was previously employed as an Independent Director by Achaogen, Inc., an Executive Vice President-Commercial by Seattle Genetics, Inc., a Vice President-Marketing by Dendreon Corp., a Marketing Director by Genentech, Inc., and an Associate by McKinsey & Co., Inc. He received his undergraduate degree from Washington University in St. Louis, a graduate degree from Haas School of Business and a doctorate degree from Haas School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-09 | 146,890 ( 0.01% ) | 9 M $ | 2026-02-27 |
| Companies | Position | Start |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Executive Officer | 2023-10-31 |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Director/Board Member | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ACHAOGEN | Director/Board Member | 2015-06-09 |
| SEAGEN INC. | Corporate Officer/Principal | 2015-01-29 |
| DENDREON CORPORATION | Sales & Marketing | - |
Genentech, Inc.
Genentech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | 2009-12-31 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
Genentech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions